Department of Osteonecrosis and Hip Surgery, The Third Hospital of Hebei Medical, Shijiazhuang, Hebei, China.
Department of Orthopedics, The Chest Hospital of Hebei Province, Shijizhuang, Hebei, China.
Front Cell Infect Microbiol. 2023 Jan 27;13:1106097. doi: 10.3389/fcimb.2023.1106097. eCollection 2023.
This study aims to evaluate the diagnostic value of blood metagenomic next-generation sequencing (mNGS) in detecting pathogens from patients clinically diagnosed as acute hematogenous osteomyelitis (AHO).
This retrospective study enrolled 66 patients with AHO. The test results of mNGS and bacterial culture on different samples, including blood and puncture fluid samples, from patients with AHO were compared to explore the diagnostic value of blood mNGS. Besides, this study also explored the efficacy of blood mNGS in decision making for antibiotic administration and analyzed the factors associated with the positive result of blood mNGS.
The most common causative pathogens were and . The sensitivity of blood mNGS (77.3%) was higher than that of blood culture (42.4%) (<0.001), while the turnaround time of blood mNGS (2.1 ± 0.4 d) is much less than that of blood culture (6.0 ± 2.1 d) (<0.001). Besides, the sensitivity of blood mNGS tests (77.3%) was slightly lower than that of puncture fluid mNGS (89.4%). Furthermore, detection comparison at pathogen level unravels that blood mNGS might be suitable for diagnosing AHO caused by common pathogens, while puncture fluid mNGS could be considered as preferred examination in diagnosing AHO caused by uncommon pathogens. Finally, three independent factors associated with the true positive result of blood mNGS in patients with AHO were identified, including Gram-positive pathogens (OR=24.4, 95% CI = 1.4-421.0 for ; OR=14.9, 95%CI= 1.6-136.1 for other Gram-positive bacteria), body temperature at sampling time (OR=8.2, 95% CI = 0.6-107.3 for body temperature of >38.5°C; OR=17.2, 95% CI = 2.0-149.1 for patients who were chilling), and no use of antibiotics before sampling (OR=8.9, 95% CI =1.4-59.0).
This is the first report on evaluating and emphasizing the importance of blood mNGS in diagnosing AHO. Blood sample might be an alternative sample for puncture fluid for mNGS, and its extensive application in diagnosing AHO could be expected.
本研究旨在评估血液宏基因组下一代测序(mNGS)在检测临床诊断为急性血源性骨髓炎(AHO)患者病原体方面的诊断价值。
本回顾性研究纳入了 66 例 AHO 患者。比较了 mNGS 和不同样本(包括血液和穿刺液样本)细菌培养的检测结果,以探讨血液 mNGS 的诊断价值。此外,本研究还探讨了血液 mNGS 在抗生素使用决策中的作用,并分析了与血液 mNGS 阳性结果相关的因素。
最常见的病原体为 和 。血液 mNGS 的灵敏度(77.3%)高于血液培养(42.4%)(<0.001),而血液 mNGS 的周转时间(2.1±0.4 d)明显短于血液培养(6.0±2.1 d)(<0.001)。此外,血液 mNGS 检测的灵敏度(77.3%)略低于穿刺液 mNGS(89.4%)。进一步对病原体水平的检测结果比较表明,血液 mNGS 可能适用于诊断常见病原体引起的 AHO,而穿刺液 mNGS 可作为诊断不常见病原体引起的 AHO 的首选检查方法。最后,确定了与 AHO 患者血液 mNGS 阳性结果相关的三个独立因素,包括革兰阳性病原体(OR=24.4,95%CI=1.4-421.0 ;OR=14.9,95%CI=1.6-136.1 )、采样时的体温(OR=8.2,95%CI=0.6-107.3 ;OR=17.2,95%CI=2.0-149.1 )和采样前未使用抗生素(OR=8.9,95%CI=1.4-59.0)。
这是首个评估和强调血液 mNGS 在诊断 AHO 中的重要性的报告。血液样本可能是穿刺液 mNGS 的替代样本,预计其在诊断 AHO 中的广泛应用。